MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review

A. Younas, M. Qadri, R. Noor, T. Khan, M. Anwar, I. Shahid, HA. Azam Raja, A. Munir, M. Shabih, SH. Ali Inam (Lahore, Pakistan)

Meeting: 2025 International Congress

Keywords: Levodopa(L-dopa)

Category: Dystonia (Other)

Objective: To examine the safety and efficacy of co-careldopa for motor recovery in post-stroke patients.

Background: The use of co-careldopa for improving motor function in post- stroke patients remains a topic of interest. While widely used in Parkinson’s disease, its role in stroke rehabilitation remains largely unknown. Hence, we conducted a systematic review to clarify the role of co-careldopa in enhancing motor function in post-stroke patients.

Method: A comprehensive search was conducted on PubMed, Google Scholar, and the Cochrane Library from inception to July 2024.Only randomized controlled trials and clinical trials were included, focusing on post-stroke patients treated with co-careldopa, compared to a placebo. The primary outcome assessed was motor function improvement, assessed using Rivermead Mobility Index (RMI) and Barthel Index. Secondary outcomes including psychological and cognitive impact and adverse events were also noted.

Results: Four studies with 1746 participants were included. Scheidtmann et al found significant motor improvement, while Shamsei et al. reported a 79.1% improvement in motor function. However, Ford et al. showed no significant improvement in walking ability after 12 months. Psychological outcomes showed improved mood and reduced caregiver burden in the co-careldopa group, but no significant impact on cognitive recovery. Co-careldopa was generally well-tolerated, with no significant adverse events compared to placebo.

Conclusion: Co-careldopa shows potential in enhancing motor recovery, particularly in the acute and subacute phases of stroke. However, the evidence for sustained improvements in walking and cognitive recovery remains inconclusive. Despite potential benefits, further research is needed to delineate the patient subgroups most likely to benefit from this intervention.

Table 1. Outcomes for motor function

Table 1. Outcomes for motor function

To cite this abstract in AMA style:

A. Younas, M. Qadri, R. Noor, T. Khan, M. Anwar, I. Shahid, HA. Azam Raja, A. Munir, M. Shabih, SH. Ali Inam. Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/safety-and-effectiveness-of-co-careldopa-for-motor-recovery-in-post-stroke-patients-a-systematic-review/. Accessed October 22, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/safety-and-effectiveness-of-co-careldopa-for-motor-recovery-in-post-stroke-patients-a-systematic-review/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley